Clinical Performance Evaluation of Size‐Selective Placental Cell‐Free DNA Enrichment for Non‐Invasive Prenatal Testing of Fetal Copy Number Variants
Prenatal Diagnosis · 2026
DOI: 10.1002/pd.70262 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Prenatal Diagnosis, 2026. Verfasst von Xiaoyi Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, Longgang District Maternity & Child Healthcare Hospital (Affiliated Shenzhen Women and Children's Hospital (Longgang) of Shantou …. Hauptthemen laut MEDLINE: DNA Copy Number Variations, Cell-Free Nucleic Acids, Noninvasive Prenatal Testing, Prenatal Diagnosis. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Natural Science Foundation of Shenzhen Municipality, Medical and Health Technology Research Project, Special Funds for Science and Technology, Innovation Longgang District of Shenzhen City.
Abstract (Originalsprache)
Objective
To evaluate the performance of low‐depth non‐invasive prenatal testing (NIPT) using cell‐free DNA enrichment for detecting fetal copy number variations (CNVs) and to assess its clinical utility.
Methods
A retrospective analysis was conducted on 86,012 pregnant women who underwent NIPT with size‐selective cell‐free DNA enrichment. CNVs were detected using a Hidden Markov Model. Following prenatal diagnosis of positive cases through chromosome microarray analysis (CMA), positive predictive values (PPVs) were evaluated across different CNV sizes and fetal fractions, and the accuracy of CNV breakpoint validation was assessed.
Results
DNA enrichment achieved a mean fetal fraction of 18.88% ± 5.82%. A total of 340 CNVs were detected in 339 pregnant women, with an overall CNV positive rate of 0.39% [95% CI: 0.35%, 0.44%] (339/86, 012), including 249 deletions and 91 duplications. The total PPV for CNVs was 59.20% [95% CI: 52.05%, 66.00%] (119/201). For the accuracy of CNV size and position, 85.83% [95% CI: 78.01%, 91.29%] (103/120) of CNVs had size discrepancies < 25% compared to CMA, and 80.42% [95% CI: 74.71%, 85.13%] (193/240) of breakpoints were within 1 Mb. The 22q11.21 deletion was the most frequent CNV (16.76% [95% CI: 13.04%, 21.26%] (57/340)), with a PPV of 40.00% [95% CI: 25.28%, 56.61%] (16/40).
Conclusion
An elevated fetal fraction improves breakpoint accuracy. In addition to increasing sequencing depth, it represents a promising technical approach to optimizing the performance of NIPT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Central Laboratory, Longgang District Maternity & Child Healthcare Hospital (Affiliated Shenzhen Women and Children's Hospital (Longgang) of Shantou University Medical College), Shenzhen, Guangdong, China.
- Longgang District Key Laboratory for Birth Defects Prevention, Shenzhen, China.
- GuangDong Engineering Technology Research Center of Genomics and Precision Imaging, Shenzhen, China.
ORCID-Profile: Xiaoyi Liu, Xianzhen Cao, Liang Hu, Yanan Liu, Shuxian Zeng, Weiqiang Liu, Fengxiang Wei
Förderung
- Natural Science Foundation of Shenzhen Municipality
- Medical and Health Technology Research Project, Special Funds for Science and Technology, Innovation Longgang District of Shenzhen City
Zitieren
APA
Liu, X., Cao, X., Hu, L., Liu, Y., Zeng, S., Liu, W., & Wei, F. (2026). Clinical Performance Evaluation of Size‐Selective Placental Cell‐Free DNA Enrichment for Non‐Invasive Prenatal Testing of Fetal Copy Number Variants. Prenatal Diagnosis. https://doi.org/10.1002/pd.70262
Vancouver
Liu X, Cao X, Hu L, Liu Y, Zeng S, Liu W, et al. Clinical Performance Evaluation of Size‐Selective Placental Cell‐Free DNA Enrichment for Non‐Invasive Prenatal Testing of Fetal Copy Number Variants. Prenatal Diagnosis. 2026. doi:10.1002/pd.70262
BibTeX
@article{Liu2026,
author = {Liu, Xiaoyi and Cao, Xianzhen and Hu, Liang and Liu, Yanan and Zeng, Shuxian and Liu, Weiqiang and Wei, Fengxiang},
title = {Clinical Performance Evaluation of Size‐Selective Placental Cell‐Free DNA Enrichment for Non‐Invasive Prenatal Testing of Fetal Copy Number Variants},
journal = {Prenatal Diagnosis},
year = {2026},
doi = {10.1002/pd.70262}
}
EUVIMED